Loading
Old version — revision 2
This is a fixed snapshot of Maximum human lifespan, saved by Import. It is not edited and it is not updated; the article may have changed since. 1 later revision has been saved.
Edit summary: Re-import of content/maximum-human-lifespan.md — the file changed after the initial import. Not an edit.
Read the current versionWhat changed sinceWhat this revision changedAll 3 revisions
The longest duration a human being has lived or could live, distinct from average life expectancy and disputed as to whether any fixed ceiling exists.
Maximum human lifespan is the greatest age a human being has attained or, in its theoretical sense, the greatest age a human could attain under the best achievable conditions. It is a property of the extreme tail of the mortality distribution and behaves very differently from life expectancy, which is a mean. Whether the species has a fixed ceiling, and if so where, has been argued in the demographic literature since the 1990s without resolution.
The two quantities are routinely confused. Life expectancy at birth is the mean age at death of a hypothetical cohort experiencing current age-specific mortality rates. It has risen dramatically over two centuries, mostly because fewer people die young. Maximum lifespan is a record, an order statistic drawn from the extreme right tail, and it responds far less to public-health improvement. Saving infants does not lengthen the tail; it only sends more people into it.
The distinction disciplines several common arguments. Classical claims that Bronze Age humans lived to 30 describe an average dragged down by infant mortality, not a species whose members died at 30. It also explains why record ages have crept upward far more slowly than mean ages: the tail grows because the population at risk grows, not because the biology has changed. A third quantity, Healthspan, tracks the years lived in good function and moves independently of both. Whether added years are healthy ones is the subject of Compression of morbidity.
Terminology"Maximum lifespan" is used in at least three senses: the oldest verified individual, the age by which some specified fraction of a cohort has died, and a hypothesized biological ceiling. Papers often switch between them without warning, which accounts for a good deal of the apparent disagreement.
Jeanne Calment of Arles, France, died in 1997 at 122 years and 164 days, an age validated against parish and civil records by a team led by the demographer Jean-Marie Robine. In the decades since, no verified case has come within three years of it. Sarah Knauss, who died in the United States in 1999, and Kane Tanaka, who died in Japan in 2022, both reached 119. Later record holders, including Lucile Randon and Maria Branyas Morera, died at 117 or 118.
The stability of Calment's record is itself a data point. Over a period in which the number of people surviving past 100 rose worldwide by more than an order of magnitude, the maximum reported age at death did not rise with it. Interpretations differ sharply. One camp reads this as a ceiling; the other reads it as the ordinary behavior of a sparse extreme tail.
Calment's case has been challenged. In 2019 the Russian researchers Nikolay Zak and Valery Novoselov argued that her daughter Yvonne had assumed her identity, which would put the true age at about 99. A rebuttal by Robine and colleagues reviewed the documentary and testimonial evidence and concluded that the substitution hypothesis was inconsistent with the record.1 Mainstream demography continues to treat the case as validated, while acknowledging that any single-record claim rests on the quality of the documents.
The 2016 paper by Dong, Milholland and Vijg is the reference point for the "hard limit" position.2 Using the International Database on Longevity and national datasets, they reported that the maximum reported age at death rose until roughly 1995 and then stopped, and they inferred an average ceiling near 115, with 125 as a practical absolute. The rebuttals published the following year objected that the breakpoint was chosen after inspecting the data, that the analysis discarded most of the available information, and that the same dataset supports a continued slow rise.
Barbi and colleagues took a different route. They fitted hazard curves to Italian semi-supercentenarians and found that the annual probability of death flattens after 105 instead of continuing to climb.3 A flat hazard implies a long, thin tail, not a wall: if the annual risk of death holds near one in two, ages beyond 120 remain possible but exceedingly rare. Whether the plateau is real remains open. Saul Newman has argued that clerical error in age records produces plateaus of exactly this shape, an argument closely related to his later work on Blue Zones.4
What each side is actually claimingThe "limit" position holds that biology truncates the tail: something goes wrong at an age no current intervention touches. The "no limit" position holds only that the data cannot distinguish a truncated tail from a very thin one, not that people will live to 150. Almost nobody argues that current medicine can produce a 130-year-old.
Record quality limits every claim in this area. Validating an age of 110 requires a birth record created before the person could have had any reason to falsify it, an unbroken chain of identity documents, and an official death record. Only a small minority of claims to a very high age survive that process, and the validated lists maintained by longevity researchers are correspondingly short.
The failure modes are systematic, not random. Age exaggeration rises where pensions are linked to age, where birth registration was late or incomplete, and where a false record brings the largest reward. Japan's 2010 audit of its centenarian registry found very large numbers of people recorded as living who were dead or untraceable. Because the errors run in one direction, with records overstating age far more often than understating it, they contaminate exactly the tail that limit studies analyse.
Comparative work offers little support for a species-specific hard stop. In some organisms mortality rates do not rise measurably with age at all, the subject of Negligible senescence, and lifespan across mammals varies by more than two orders of magnitude with no obvious mechanism setting an individual ceiling. Invertebrate genetics makes the point from the other side. A daf-2 mutation roughly doubles lifespan in Caenorhabditis elegans, the result reported by Cynthia Kenyon's laboratory, so a species-typical maximum is not necessarily fixed, though the mammalian versions of the same manipulation move lifespan far less. Within humans, the identified genetic contributions to extreme longevity are modest and inconsistently replicated, and the heritability of lifespan estimated from pedigrees is low once assortative mating is accounted for.
Mechanistic candidates for a ceiling have been proposed, and none has held up cleanly. Telomere attrition sets a replicative limit in cultured cells but correlates weakly with human survival. Accumulated senescent cells and stem cell exhaustion progress steadily instead of hitting a threshold. Chronic sterile inflammation rises with age but is at least partly downstream of other damage. Each explains decline; none explains a wall.
Supercentenarian biology does show a compression of terminal decline. The oldest old tend to die of general frailty, systemic amyloidosis and organ failure, not of the cancers and cardiovascular events that kill people in their seventies. This is sometimes read as evidence that at the tail the aging processes themselves, and not any specific disease, become the proximate cause of death, the core premise of the Geroscience hypothesis.
No intervention has extended maximum human lifespan. Caloric restriction extends maximum lifespan in rodents; the human data address biomarkers and cardiometabolic risk, not the tail. Senolytics, Rapamycin and other geroprotector candidates have not been tested on a timescale that could show such an effect, and no validated surrogate exists that would let them be tested faster. Arguments about Longevity escape velocity advanced by Aubrey de Grey and others concern whether that will change; they are not evidence that it has. Cryonics is the fallback bet for those who expect no such change within their own lifetime.
The question that would settle the debate is empirical and slow: as the number of people reaching 105 keeps growing, does the maximum reported age at death grow with it? Extreme-value theory makes a testable prediction. A thin exponential tail produces a slowly rising record, and a truncated one produces a flat record. The datasets needed to tell them apart accumulate at a rate set by human generations. Better birth registration in the cohorts now entering old age will do more to resolve the question than any new statistical method, since the current dispute concerns data quality at least as much as biology. A second, faster route would be a molecular measure that tracked the tail directly. If an epigenetic or proteomic measure could distinguish a 112-year-old who will reach 120 from one who will not, the ceiling question would become answerable without waiting for the deaths.
paperRobine, J.-M., Allard, M., Herrmann, F.R. and Jeune, B. "The real facts supporting Jeanne Calment as the oldest ever human." The Journals of Gerontology: Series A, 2019.↩Written by members of the team that validated the record originally, replying to the identity-substitution claim.
paperDong, X., Milholland, B. and Vijg, J. "Evidence for a limit to human lifespan." Nature, 2016.↩The 1995 breakpoint the ceiling claim rests on was chosen after inspecting the data, and several technical comments in Nature disputed the analysis the following year.
paperBarbi, E., Lagona, F., Marsili, M., Vaupel, J.W. and Wachter, K.W. "The plateau of human mortality: Demography of longevity pioneers." Science, 2018.↩Italian records only, with each individual age validated; whether the plateau appears in other national datasets is disputed.
paperNewman, S.J. "Errors as a primary cause of late-life mortality deceleration and plateaus." PLoS Biology, 2018.↩A modelling argument that plateaus can be generated by age-reporting error; it does not present newly validated ages.